Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
<h4>Background</h4> <p>Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis. Mepolizumab, an anti–interleukin-5 monoclonal antibody, reduces blood eosinophil counts and may have value in the treatment of eosinophilic granulomatosis with polyangiitis.</p&g...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Journal article |
| 语言: | English |
| 出版: |
Massachusetts Medical Society
2017
|